Armata Pharmaceuticals (ARMP) Cash from Investing Activities Growth (1y) (2014 - 2026)
Armata Pharmaceuticals (ARMP) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Armata Pharmaceuticals |
282.74 Mn |
277.99 Mn |
- |
36.36% |
| Date | Value |
|---|
| Mar 31, 2026 |
36.36% |
| Dec 31, 2025 |
-167.53% |
| Sep 30, 2025 |
28.82% |
| Jun 30, 2025 |
89.09% |
| Mar 31, 2025 |
60.40% |
| Dec 31, 2024 |
103.22% |
| Sep 30, 2024 |
90.32% |
| Jun 30, 2024 |
-515.32% |
| Mar 31, 2024 |
87.56% |
| Dec 31, 2023 |
-625.27% |
| Sep 30, 2023 |
-171.41% |
| Jun 30, 2023 |
80.46% |
| Mar 31, 2023 |
-751.69% |
| Dec 31, 2022 |
299.56% |
| Sep 30, 2022 |
-122.34% |
| Jun 30, 2022 |
-479.59% |
| Mar 31, 2022 |
20.81% |
| Dec 31, 2021 |
37.70% |
| Sep 30, 2021 |
-618.52% |
| Jun 30, 2021 |
28.21% |
